Evonile Pharma Limited (BOM:500672)
India flag India · Delayed Price · Currency is INR
1,762.40
+48.05 (2.80%)
At close: Nov 6, 2026

Evonile Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
2,526525520.7449.8194.21,584
Short-Term Investments
5006,0505,8505,4005,3503,579
Cash & Short-Term Investments
3,0266,5756,3715,8505,5445,163
Cash Growth
-50.99%3.21%8.91%5.51%7.38%3.80%
Accounts Receivable
223.5370.5401.4414.7361.6445.6
Other Receivables
-80.98994.7130116.4
Receivables
223.5451.4490.4509.4491.6566.6
Inventory
1,642533.2411.1448.6547.2570.7
Prepaid Expenses
-27.624.718.929.538.5
Other Current Assets
358.395.1161.3165.9160.8748.6
Total Current Assets
5,2497,6837,4586,9936,7737,087
Property, Plant & Equipment
58.128.845.469.4192.5236.5
Long-Term Deferred Tax Assets
262.9134.7154.8153.7158271.8
Other Long-Term Assets
4,1641,9371,8202,0342,7061,974
Total Assets
22,7779,7839,4789,2499,8299,576

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1,937546.5514.7615.9596.7722
Accrued Expenses
-278.6297.9356.7343.3562.6
Short-Term Debt
5,125--0.2--
Current Portion of Leases
-16.418.518.841.257.4
Current Income Taxes Payable
162.2162.9134.474.860.882.6
Other Current Liabilities
4,857445.3455505.6552.9739.6
Total Current Liabilities
12,0811,4501,4211,5721,5952,164
Long-Term Leases
-15.732.150.7173.9182.7
Pension & Post-Retirement Benefits
-136.8144.5145.7188.4255.6
Other Long-Term Liabilities
143.12.231.432.7115.656.2
Total Liabilities
15,0591,6041,6291,8012,0732,659

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
123.4123.4123.4123.4123.4123.4
Retained Earnings
-8,0197,6907,2887,5976,779
Comprehensive Income & Other
7,59436.436.436.43614.2
Shareholders' Equity
7,7178,1787,8507,4487,7576,917
Total Liabilities & Equity
22,7779,7839,4789,2499,8299,576

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
7,96032.150.669.7215.1240.1
Net Cash (Debt)
-4,9356,5436,3205,7805,3294,923
Net Cash Growth
-3.53%9.34%8.46%8.25%13.19%
Net Cash Per Share
-199.84265.00255.97234.10215.83199.38
Filing Date Shares Outstanding
24.6924.6924.6924.6924.6924.69
Total Common Shares Outstanding
24.6924.6924.6924.6924.6924.69
Working Capital
-6,8326,2336,0385,4215,1784,923
Book Value Per Share
312.61331.23317.92301.66314.15280.14
Tangible Book Value
-5,3258,1787,8507,4487,7576,917
Tangible Book Value Per Share
-215.72331.23317.92301.66314.15280.14
Buildings
---0.50.50.9
Machinery
-18.7-45.147.780.5
Leasehold Improvements
-39.337.940.146.346.3